Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1971 1
1972 3
1973 2
1974 1
1979 1
1981 1
1982 2
1983 4
1984 7
1985 6
1986 7
1987 2
1988 1
1989 3
1990 1
1991 6
1993 2
1994 1
1995 3
1996 1
1997 2
1998 3
1999 3
2000 1
2001 1
2002 1
2003 1
2004 1
2005 3
2006 1
2007 2
2008 6
2009 5
2010 2
2011 5
2012 1
2013 7
2014 13
2015 9
2016 13
2017 12
2018 8
2019 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
[Psyche and cancer].
Lopez M, Cauchi C, Sergi D, Amodio A, Paoletti G, Vici P, Di Lauro L. Lopez M, et al. Among authors: di lauro l. Clin Ter. 2010;161(1):69-75. Clin Ter. 2010. PMID: 20393684 Italian.
Triple positive breast cancer: a distinct subtype?
Vici P, Pizzuti L, Natoli C, Gamucci T, Di Lauro L, Barba M, Sergi D, Botti C, Michelotti A, Moscetti L, Mariani L, Izzo F, D'Onofrio L, Sperduti I, Conti F, Rossi V, Cassano A, Maugeri-Saccà M, Mottolese M, Marchetti P. Vici P, et al. Among authors: di lauro l. Cancer Treat Rev. 2015 Feb;41(2):69-76. doi: 10.1016/j.ctrv.2014.12.005. Epub 2014 Dec 19. Cancer Treat Rev. 2015. PMID: 25554445 Free article. Review.
Metformin and breast cancer: basic knowledge in clinical context.
Pizzuti L, Vici P, Di Lauro L, Sergi D, Della Giulia M, Marchetti P, Maugeri-Saccà M, Giordano A, Barba M. Pizzuti L, et al. Among authors: di lauro l. Cancer Treat Rev. 2015 May;41(5):441-7. doi: 10.1016/j.ctrv.2015.03.002. Epub 2015 Mar 17. Cancer Treat Rev. 2015. PMID: 25816698 Review.
Emerging biological treatments for uterine cervical carcinoma.
Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Mancini E, Vincenzoni C, Barba M, Maugeri-Saccà M, Giovinazzo G, Venuti A. Vici P, et al. Among authors: di lauro l. J Cancer. 2014 Jan 5;5(2):86-97. doi: 10.7150/jca.7963. eCollection 2014. J Cancer. 2014. PMID: 24494026 Free PMC article. Review.
Androgen receptor and antiandrogen therapy in male breast cancer.
Di Lauro L, Barba M, Pizzuti L, Vici P, Sergi D, Di Benedetto A, Mottolese M, Speirs V, Santini D, De Maria R, Maugeri-Saccà M. Di Lauro L, et al. Cancer Lett. 2015 Nov 1;368(1):20-25. doi: 10.1016/j.canlet.2015.07.040. Epub 2015 Aug 11. Cancer Lett. 2015. PMID: 26276719 Free article. Review.
Cancer stem cells: are they responsible for treatment failure?
Maugeri-Saccà M, Vici P, Di Lauro L, Barba M, Amoreo CA, Gallo E, Mottolese M, De Maria R. Maugeri-Saccà M, et al. Among authors: di lauro l. Future Oncol. 2014 Oct;10(13):2033-44. doi: 10.2217/fon.14.126. Future Oncol. 2014. PMID: 25396775 Review.
Hot flushes in women with breast cancer: state of the art and future perspectives.
Barba M, Pizzuti L, Sergi D, Maugeri-Saccà M, Vincenzoni C, Conti F, Tomao F, Vizza E, Di Lauro L, Di Filippo F, Carpano S, Mariani L, Vici P. Barba M, et al. Among authors: di lauro l. Expert Rev Anticancer Ther. 2014 Feb;14(2):185-98. doi: 10.1586/14737140.2013.856271. Epub 2013 Dec 6. Expert Rev Anticancer Ther. 2014. PMID: 24313623 Review.
Immunologic treatments for precancerous lesions and uterine cervical cancer.
Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Cavallotti C, Paolini F, Venuti A. Vici P, et al. Among authors: di lauro l. J Exp Clin Cancer Res. 2014 Mar 26;33(1):29. doi: 10.1186/1756-9966-33-29. J Exp Clin Cancer Res. 2014. PMID: 24667138 Free PMC article. Review.
Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancer.
Maugeri-Saccà M, Barba M, Vici P, Pizzuti L, Sergi D, Catenaro T, Di Lauro L, Mottolese M, Santini D, Milella M, De Maria R. Maugeri-Saccà M, et al. Among authors: di lauro l. Crit Rev Oncol Hematol. 2016 Oct;106:132-42. doi: 10.1016/j.critrevonc.2016.08.004. Epub 2016 Aug 21. Crit Rev Oncol Hematol. 2016. PMID: 27637358 Review.
148 results